330 results on '"Westheim, Arne"'
Search Results
2. Einar Olav Rykke
3. The Role of Drug Therapy in Lowering Mortality and Morbidity: From Established Heart Failure to High-Risk Hypertension
4. Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
5. Medical Therapies for Heart Failure With Preserved Ejection Fraction
6. Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
7. High Prevalence of Sleep Apnea in Heart Failure Outpatients: Even in Patients With Preserved Systolic Function
8. The L-Arginine–Asymmetric Dimethylarginine Ratio Is Strongly Related to the Severity of Chronic Heart Failure. No Effects of Exercise Training
9. Impact of Systemic Hypertension on the Diagnostic Performance of B-Type Natriuretic Peptide in Patients With Acute Dyspnea
10. ANTIHYPERTENSIVE TREATMENT IN PATIENTS WITH HEART FAILURE
11. Effects of Group-Based High-Intensity Aerobic Interval Training in Patients With Chronic Heart Failure
12. Long-Term Effects of a Group-Based High-Intensity Aerobic Interval-Training Program in Patients With Chronic Heart Failure
13. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: results from the breathing not properly multinational study
14. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
15. Antihypertensive treatment in patients with heart failure
16. β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry
17. Improved quality of life in Norwegian heart failure patients after follow-up in outpatient heart failure clinics: results from the Norwegian heart failure registry
18. Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: Life, scope, and value
19. Group-based aerobic interval training in patients with chronic heart failure: Norwegian Ullevaal Model
20. N-Terminal pro-B-Type Natriuretic Peptide in Risk Stratification after Acute Myocardial Infarction in Patients on Long-Term Beta-Adrenergic Receptor Blocker Therapy
21. Predictors of Elevated B-Type Natriuretic Peptide Concentrations in Dyspneic Patients Without Heart Failure: An Analysis From the Breathing Not Properly Multinational Study
22. A Comparison of the Two β-Blockers Carvedilol and Atenolol on Left Ventricular Ejection Fraction and Clinical Endpoints after Myocardial Infarction: A Single-Centre, Randomized Study of 232 Patients
23. Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea
24. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study
25. Hormone Replacement Therapy Does Not Affect Plasma Homocysteine in Postmenopausal Women with Coronary Artery Disease: Free Tissue Factor Pathway Inhibitor Antigen, a Circulating Anticoagulant, Is Related to Plasma Homocysteine
26. B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study
27. INSIGHT and NORDIL
28. Knud Holck Landmark
29. Hjertesvikt med normal ejeksjonsfraksjon
30. Evidence of Excess Hereditary Predisposition in Women with Angiographically Documented Coronary Artery Disease
31. INSIGHT and NORDIL
32. ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
33. High cardiovascular risk profile in patients with sleep apnea
34. Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
35. Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
36. Baseline Anemia Is Not a Predictor of All-Cause Mortality in Outpatients With Advanced Heart Failure or Severe Renal Dysfunction
37. Inflammatory markers as related to disease severity in patients with chronic heart failure: Limited effects of exercise training
38. The role of beta-blockers in the treatment of chronic heart failure
39. Characteristics, Implementation of Evidence-Based Management and Outcome in Patients with Chronic Heart Failure Results from the Norwegian Heart Failure Registry
40. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure
41. Warning on Diuretic Use
42. Renal Function in Outpatients With Chronic Heart Failure
43. SERUM PHOSPHATE AND SYMPATHETIC TONE IN MILD ESSENTIAL HYPERTENSION
44. BLOOD PLATELET RELEASE CORRELATES WITH SERUM LIPIOS IN 50 YEAR OLD MEN WITH ESSENTIAL HYPERTENSION
45. EFFECT OF EXERCISE TRAINING IN PATIENTS WITH ESSENTIAL HYPERTENSION
46. Hemodynamic Effects at Rest and during Exercise in Long-term Treatment with Prazosin in Chronic Congestive Heart Failure
47. Pain and Quality of Life in Hospitalized Patients with Heart Failure
48. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
49. Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty‐year follow‐up of middle‐aged men
50. Abstract 3794: Long-term Effects Of An Aerobic Training Program On Exercise Tolerance And Quality Of Life In Patients With Chronic Heart Failure. A Randomised Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.